Drug Profile
VBI 2501
Alternative Names: VBI-2501; Zika virus eVLP vaccine - VBI Vaccines; Zika virus vaccine - VBI VaccinesLatest Information Update: 29 Sep 2020
Price :
$50
*
At a glance
- Originator VBI Vaccines
- Class Virus-like particle vaccines; Zika virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Zika virus infection
Most Recent Events
- 15 Sep 2020 Preclinical trials in Zika virus infection (Prevention) in USA (unspecified route), before september 2020 (VBI Vaccines pipeline, September 2020)
- 15 Sep 2020 VBI Vaccines plans additional animal testing for Zika virus infection in USA (VBI Vaccines pipeline, September 2020)